분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-07-27 17:21:15 , Hit : 1185
 Chinese Scientists To Test Gene Modifying Technique ‘CRISPR’ On Humans For The First Time

Science World Report

First Posted: Jul 23, 2016 05:30 AM EDT

It will be the first attempt ever that a group of Chinese scientists will inject genetically modified cells into human beings next month. The genes have been modified using the CRISPR-Cas9 gene-editing technique. The trial will begin from next month at the West China Hospital, Sichuan University.

Lead oncologist Lu You and his team will test gene-edited cells on lung cancer patients on whom treatments including chemotherapy and radiation therapy have already failed. What the team will do is they will extract immune cells known as T cells from the blood of the patients and use CRISPR-Cas9 to modify them. They will try to eliminate a gene from the cells that encodes a protein named PD-1, which normally keeps immune cells in check but is also used by cancer cells as a defensive mechanism.

The researchers are hoping that after they multiply the modified cells in the lab and re-introduce them into the patients' bloodstream, they will center the cancer and eliminate it. However, it is first to be made sure that the technique is safe, reported Digital Trends.

In the first trial, which begins in August, the research team will inject the CRISPR-edited cells in only one of the three patients in the group. After observing the patient if the team is satisfied by the results, they will perform the same treatment on the second patient. Future trials will depend on how effective the technique is compared to other types of treatment.

"This technique is of great promise in bringing benefits to patients, especially the cancer patients whom we treat every day," said Lu You, reported Daily Mail.

You said that the technology will have wide applications if it has good safety and shows certain efficacy. In fact, it has the potential to become an alternative biotechnology treatment to replace or complement the existing single-antibody drugs, he added, according to journal Nature.

This is for the first time that the CRISPR-Cas9 gene editing technique will be applied on human beings. Previously, Chinese scientists have tested the technique on human embryos and in monkeys and dogs.







1087   네안데르탈인과 이웃에 살았던 현생인류의 두개골 발견  이성욱 2015/02/03 1151
1086   옥스포드 나노포어, 휴대용 시퀀서 미니온 출시 임박  이성욱 2015/05/08 1153
1085   유전자치료제 연구개발 및 규제 동향 2015-식품의약품안전처  이성욱 2016/01/20 1155
1084   [바이오토픽] 브로드 연구소, 열띤 CRISPR 특허전쟁에서 승리  이성욱 2017/02/16 1155
1083   특허전쟁: 미국 특허청, CRISPR의 특허권 중재 시작  이성욱 2016/03/08 1158
1082   정밀의학의 끝: 개인화된 종양백신을 개발하는 과학자들  이성욱 2016/04/26 1158
1081   부모의 특징을 자식에게 전달하는 방식: 박테리아의 DNA  이성욱 2015/02/19 1164
1080   에볼라 확산원인에 대한 새로운 주장  이성욱 2015/01/06 1167
1079   미국 과학·공학·의학 아카데미, 「GM 베이비」의 진행방향에 대한 윤곽 발표  이성욱 2017/02/16 1167
1078   인류의 역사를 고스란히 보여주는 결핵균의 게놈  이성욱 2015/01/21 1169
1077   [바이오토픽] C형간염을 3주 만에 치료하는 DAA 3제요법  이성욱 2015/11/02 1179
1076   의문이 제기된 `젊은 피`의 항노화 효과  이성욱 2015/05/22 1181
1075   세계 20여 개국 과학자들, 유전자편집 정상회담 개최  이성욱 2015/12/05 1181
  Chinese Scientists To Test Gene Modifying Technique ‘CRISPR’ On Humans For The First Time  이성욱 2016/07/27 1185
1073   Cost to Develop a Drug More Than Doubles to $2.56 Billion  이성욱 2014/11/21 1186
1072   FDA approves 9-valent HPV vaccine for certain cancers  이성욱 2014/12/12 1188
1071   [미국] 유전자가위 규제 마련 지연과 기업들의 움직임  이성욱 2016/07/21 1193
1070   Gilead wins European approval of next-generation hepatitis C drug  이성욱 2014/11/20 1197
1069   RNA-Based Therapeutics and Vaccines  이성욱 2015/09/21 1201
1068   유전자편집치료에 희망을 준 백혈병치료  이성욱 2015/11/11 1201

[1][2][3][4][5][6][7][8][9] 10 ..[64] [다음 10개]
 

Copyright 1999-2023 Zeroboard / skin by ROBIN